guanabenz has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, M; George, SE; Ghosh, S; Hota, M; Kesavapany, S; Lee, IC; Shenolikar, S; Sundaram, JR; Tan, EK; Wu, Y | 1 |
1 other study(ies) available for guanabenz and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
PromISR-6, a Guanabenz Analogue, Improves Cellular Survival in an Experimental Model of Huntington's Disease.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Cell Survival; Eukaryotic Initiation Factor-2; Fibroblasts; Guanabenz; Huntington Disease; Mice; Phosphorylation; Protein Aggregates | 2019 |